Skip to content

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

News

Choose Year
Search Press Releases

Found 172 Results

November 9, 2018

Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing

November 6, 2018

Sernova Establishes Comprehensive North American Investor Relations and Communications Strategy

October 23, 2018

Sernova-HemAcure Consortium to Present Achievements in Development of a Regenerative Medicine Approach to Treat Hemophilia A

July 23, 2018

Sernova Completes Oversubscribed Private Placement of $2,754,000

July 16, 2018

Sernova Announces $2,000,000 First Closing of Private Placement

July 5, 2018

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

June 26, 2018

Sernova Announces $2 Million Private Placement Financing

May 14, 2018

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch Clinical Study

May 8, 2018

Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator

May 4, 2018

Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

«...10...14 15 161718 »

IR Contact

David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

700 Collip Circle
Suite 114,
London, ON, Canada N6G 4X8
info@sernova.com

Company

About Us
Leadership
Board of Directors
Careers
Contact

Science

Our Focus
Type 1 diabetes
Pipeline
Library

Investors

Overview
News
Events
Financial Reports
Stock Information
Corporate Governance

Privacy Policy
Legal Notice

© 2025 Sernova Biotherapeutics. All rights reserved.

Scroll to Top